PC Pharma PLC reported unaudited earnings results for the second quarter and six months ended September 30, 2013. For the quarter, the company reported revenue of LKR 100,201,156, loss before taxation of LKR 41,166,246 and net loss of LKR 41,166,246 or LKR 0.41 per basic share against revenue of LKR 155,877,990, profit before taxation of LKR 17,445,275 and net profit of LKR 12,560,598 or LKR 0.12 per basic share for the same period a year ago.

For the six months, the company reported revenue of LKR 202,326,949, loss before taxation of LKR 67,572,693 and net loss of LKR 67,572,693 or LKR 0.67 per basic share against revenue of LKR 317,721,174, profit before taxation of LKR 28,529,382 and net profit of LKR 20,541,155 or LKR 0.20 per basic share for the same period a year ago. Net cash from operating activities was LKR 47,595,527 against LKR 65,309,768 for the same period a year ago.